| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.031 | 0.5 |